Rodyti straipsnį

Intensyvioji ir kritinė terapija

Anemijos gydymas

Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (atsiveria naujas langas)

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

Šaltinis‎: Crit Care Med 2009;37(4):1299-307.

Kodas‎: PubMed 19242343

DOI‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 (atsiveria naujas langas)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (atsiveria naujas langas)

Ball AM, Winstead PS.

Šaltinis‎: Pharmacotherapy 2008;28(11):1383-90.

Kodas‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (atsiveria naujas langas)

Reducing postburn injury anemia in a Jehovah's Witness patient. (atsiveria naujas langas)

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

Šaltinis‎: J Burn Care Res 2014;35(4):e258-61.

Kodas‎: PubMed 24121804

DOI‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 (atsiveria naujas langas)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (atsiveria naujas langas)

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

Šaltinis‎: Clin Ther 2008;30(12):2324-34.

Kodas‎: PubMed 19167591

DOI‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 (atsiveria naujas langas)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (atsiveria naujas langas)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Šaltinis‎: Transplant Proc 2015;47(8):2548-51.

Kodas‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (atsiveria naujas langas)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (atsiveria naujas langas)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Šaltinis‎: Crit Care Med 1999;27(11):2346-50.

Kodas‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (atsiveria naujas langas)

Erythropoietin for critically ill trauma patients: a missed opportunity? (atsiveria naujas langas)

Corwin HL, Napolitano LM

Šaltinis‎: J Trauma Acute Care Surg 2014;77(5):774-9.

Kodas‎: PubMed 25494432

DOI‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 (atsiveria naujas langas)

Postoperative management of severe acute anemia in a Jehovah's Witness. (atsiveria naujas langas)

de Araújo Azi LM, Lopes FM, Garcia LV

Šaltinis‎: Transfusion 2014;54(4):1153-7.

Kodas‎: PubMed 24117834

DOI‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 (atsiveria naujas langas)

Restrictive transfusion in geriatric trauma patients. (atsiveria naujas langas)

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

Šaltinis‎: Am Surg 2016;82(1):85-8.

Kodas‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 (atsiveria naujas langas)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (atsiveria naujas langas)

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

Šaltinis‎: J Trauma 1998;44(2):361-7.

Kodas‎: PubMed 9498512

DOI‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 (atsiveria naujas langas)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (atsiveria naujas langas)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Šaltinis‎: Crit Care 2005;9(5):R508-15.

Kodas‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (atsiveria naujas langas)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (atsiveria naujas langas)

Lindholm J, Palmér K, Frenckner B.

Šaltinis‎: Perfusion 2012;27(4):332-4.

Kodas‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (atsiveria naujas langas)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (atsiveria naujas langas)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Šaltinis‎: Am Surg 2010;76(9):951-6.

Kodas‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (atsiveria naujas langas)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (atsiveria naujas langas)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Šaltinis‎: Intensive Care Med 2013;39(11):1896-908.

Kodas‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (atsiveria naujas langas)

Transfusion-free treatment strategies for acute anemia in critical care. (atsiveria naujas langas)

Morgan CA, Byul Sarah S, Forest CP.

Šaltinis‎: JAAPA 2016;29(8):38-44.

Kodas‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (atsiveria naujas langas)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (atsiveria naujas langas)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Šaltinis‎: J Trauma 2008;65(2):285-97.

Kodas‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (atsiveria naujas langas)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (atsiveria naujas langas)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Šaltinis‎: J Trauma 2009;67(1):121-4.

Kodas‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (atsiveria naujas langas)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (atsiveria naujas langas)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Šaltinis‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Kodas‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (atsiveria naujas langas)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (atsiveria naujas langas)

Posluszny JA Jr, Napolitano LM.

Šaltinis‎: Transfusion 2014;54(12):3026-34.

Kodas‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (atsiveria naujas langas)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (atsiveria naujas langas)

Price S, Pepper JR, Jaggar SI.

Šaltinis‎: Anesth Analg 2005;101(2):325-7.

Kodas‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (atsiveria naujas langas)

Erythropoietin response is blunted in critically ill patients. (atsiveria naujas langas)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Šaltinis‎: Intensive Care Med 1997;23(2):159-62.

Kodas‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (atsiveria naujas langas)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (atsiveria naujas langas)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Šaltinis‎: Br J Anaesth 2005;94(4):442-4.

Kodas‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (atsiveria naujas langas)

Management of anemia in patients who decline blood transfusion. (atsiveria naujas langas)

Shander A, Goodnough LT

Šaltinis‎: Am J Hematol 2018;93(9):1183-91.

Kodas‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (atsiveria naujas langas)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (atsiveria naujas langas)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Šaltinis‎: Arch Surg 2012;147(3):251-5.

Kodas‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (atsiveria naujas langas)

Intravenous iron following cardiac surgery does not increase the infection rate. (atsiveria naujas langas)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Šaltinis‎: Surg Infect (Larchmt) 2006;7(4):361-6.

Kodas‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (atsiveria naujas langas)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (atsiveria naujas langas)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Šaltinis‎: Crit Care 2015;19:49.

Kodas‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (atsiveria naujas langas)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (atsiveria naujas langas)

Yoshihiro S, Hongo T, Yamamoto M, Taito S, Kataoka Y

Šaltinis‎: Crit Care Med 2024;52(4):618-25.

Kodas‎: PubMed 37962159

DOI‎: 10.1097/CCM.0000000000006114

https://pubmed.ncbi.nlm.nih.gov/37962159/ (atsiveria naujas langas)